Repurposing Drugs to Combat Aging Effects

The quest for longevity is one of humanity's oldest aspirations, often likened to the mythical pursuit of the Fountain of Youth. Recent research led by a team at Northeastern University suggests that we may not need to look far for solutions; existing drugs could potentially be repurposed to target aging-related processes, as detailed in a groundbreaking study published in Nature Aging.

Unlocking the Secrets of Longevity

Historically, the pursuit of longevity has been riddled with quick-fix fads, from dietary supplements to various treatments. However, this innovative research proposes a more evidence-based approach: leveraging our current medical arsenal to identify therapeutic agents that can influence the aging process.

Albert-László Barabási, a Distinguished University Professor and principal investigator of the study, emphasizes that the real challenge lies in pinpointing which existing medications can effectively combat the aging process. “As someone whose hair turned gray years ago, I share the universal wish for a solution that slows the aging process,” Barabási remarked.

Methodology: Mapping Aging-Related Genes

The researchers focused on aging-related genes that are implicated in 11 core biological processes, known as the "hallmarks of aging." These hallmarks include:

• Epigenetic alterations: Modifications that determine gene expression.
• Mitochondrial dysfunction: Deterioration in cellular energy production.
• Cellular senescence: The cessation of cell division.
• Stem cell exhaustion: Depletion of regenerative cells.
• Loss of proteostasis: Impaired protein homeostasis.
• Altered intercellular communication: Disturbances in the signaling between cells.

To systematically analyze these genes, the team utilized the Open Genes database, narrowing down 1,250 genes associated with the hallmarks of aging. These genes were organized within the context of the human protein interactome, a catalog of over half a million protein-protein interactions.

Drug Repurposing: A New Frontier

With the gene interactions mapped, the researchers aimed to identify existing drugs that might influence aging by examining their proximity to the aging gene networks. The team began with a comprehensive catalog of 6,442 drugs from the DrugBank database. By scoring these drugs on their potential effects on aging, they uncovered:

Among the notable drug candidates were familiar substances such as aspirin, which is presently being evaluated for its potential longevity benefits. Additionally, the study identified oxymetazoline, a nasal spray, which may enhance cellular communication—a process believed to deteriorate with age.

Evaluating Drug Effects

To assess the effects of the identified drugs, a novel metric was introduced, which captures the relationship between aging gene activity and drug actions. The aim is to determine whether a drug can restore the activity of genes that decline with age or inhibit those that become overly active. As Bnaya Gross, a postdoctoral researcher and lead author of the study, notes, "If a gene becomes less active as one ages, the goal would be to have the drug make it active again."

“This study does not provide a cure for aging, nor does it prove that any specific drug will extend human life. It offers a roadmap ... toward actionable interventions that can be tested in cells, animals and eventually humans.” – Albert-László Barabási

A Complex Interplay of Factors

The science of aging is multifaceted, influenced by genetics, environment, and molecular mechanisms. Thus, targeting aging requires a comprehensive approach that may include multiple interventions to address various hallmarks. The method discussed could lead to personalized anti-aging therapies based on individual needs.

Notably, the researchers caution that further validation through experimental trials is essential, as clinical testing will be needed to confirm the safety and efficacy of these repurposed drugs.

Conclusion and Future Directions

This innovative study lays the groundwork for future research into age-related drug interventions. By reexamining existing medications, scientists may effectively fast-track the pathway to discovering viable longevity therapies.

For additional details, please refer to the original study: Gross, B., et al. Networking-driven discovery of repurposable drugs targeting hallmarks of aging, Nature Aging (2026).

Learn more about the implications of drug repurposing in combating aging by visiting the Science X article.

References

[1] Gross, B. et al. (2026). Network-driven discovery of repurposable drugs targeting hallmarks of aging. Nature Aging.